Skip to main content

Table 1 Demographic and tumor characteristics of invasive and in situ female breast cancer cases (Surveillance, Epidemiology, and End Results-13)

From: Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype

  Invasive
  Asian/Pacific Islander Hispanic African-American Non-Hispanic White
  n = 15,933 (6.5) n = 15,355 (6.3) n = 19,105 (7.8) n = 193,513 (79.3)
Demographics     
   Diagnosis year     
1992 854 (5.4) 920 (6.0) 1,237 (6.5) 13,822 (7.1)
1993 851 (5.3) 869 (5.7) 1,231 (6.4) 13,732 (7.1)
1994 870 (5.5) 958 (6.2) 1,299 (6.8) 14,003 (7.2)
1995 984 (6.2) 995 (6.5) 1,356 (7.1) 14,333 (7.4)
1996 1,045 (6.6) 1,095 (7.1) 1,392 (7.3) 14,402 (7.4)
1997 1,253 (7.9) 1,067 (6.9) 1,453 (7.6) 15,289 (7.9)
1998 1,292 (8.1) 1,212 (7.9) 1,483 (7.8) 15,807 (8.2)
1999 1,373 (8.6) 1,264 (8.2) 1,550 (8.1) 16,048 (8.3)
2000 1,352 (8.5) 1,350 (8.8) 1,506 (7.9) 15,608 (8.1)
2001 1,491 (9.4) 1,327 (8.6) 1,526 (8.0) 16,033 (8.3)
2002 1,558 (9.8) 1,433 (9.3) 1,683 (8.8) 15,697 (8.1)
Tumor characteristics     
   Hormone receptor status     
ER+/PR+ 8,242 (51.8) 6,619 (43.1) 6,941 (36.3) 101,364 (52.4)
ER+/PR- 1,707 (10.7) 1,558 (10.1) 1,921 (10.1) 21,653 (11.1)
ER-/PR+ 324 (2.0) 250 (1.6) 374 (2.0) 3,022 (1.6)
ER-/PR- 2,504 (15.7) 2,417 (15.7) 4,243 (22.2) 24,355 (12.6)
Other/unknown 3,156 (19.8) 4,511 (29.4) 5,626 (29.4) 43,119 (22.3)
   Histology     
IDC 11,780 (73.9) 10,204 (66.5) 12,824 (67.1) 128,393 (66.3)
ILC 748 (4.7) 1,121 (7.3) 1,190 (6.2) 18,663 (9.7)
IDLC 843 (5.3) 1,152 (7.5) 1,179 (6.2) 14,963 (7.7)
Other/unknown 2,562 (16.1) 2,878 (18.7) 3,912 (20.5) 31,494 (16.3)
   Size     
<2 cm 8,669 (54.4) 7,077 (46.1) 7,904 (41.4) 108,527 (56.1)
≥ 2 cm 6,076 (38.1) 6,674 (43.5) 8,711 (45.6) 66,515 (34.4)
Unknown 1,188 (7.5) 1,604 (10.4) 2,490 (13.0) 18,471 (9.5)
  In situ
  Asian/Pacific Islander Hispanic African-American Non-Hispanic White
  n = 4,025 (8.4) n = 2,807 (5.9) n = 4,072 (8.5) n = 36,908 (77.1)
Demographics     
   Diagnosis year     
1992 115 (2.9) 110 (3.9) 177 (4.3) 1,942 (5.3)
1993 163 (4.0) 117 (4.2) 181(4.4) 1,932 (5.2)
1994 173 (4.3) 138 (4.9) 212 (5.2) 2,043 (5.5)
1995 214 (5.3) 152 (5.4) 259 (6.4) 2,313 (6.3)
1996 219 (5.4) 160 (5.7) 238 (5.8) 2,411 (6.5)
1997 245 (6.1) 199 (7.1) 300 (7.4) 2,717 (7.4)
1998 292 (7.3) 237 (8.4) 335 (8.2) 3,182 (8.6)
1999 381 (9.5) 238 (8.5) 350 (8.6) 3,306 (9.0)
2000 358 (8.9) 257 (9.2) 383 (9.4) 3,344 (9.1)
2001 447 (11.1) 279 (9.9) 412 (10.1) 3,496 (9.5)
2002 527 (13.1) 287 (10.2) 375 (9.3) 3,497 (9.5)
2003 451 (11.2) 309 (11.0) 413 (10.1) 3,326 (9.0)
2004 440 (10.9) 324 (11.5) 437 (10.7) 3,399 (9.2)
  1. Values in parentheses are percentages. ER, estrogen receptor; IDC, invasive ductal carcinoma; IDLC, invasive ducto-lobular carcinoma; ILC, invasive lobular carcinoma; PR, progesterone receptor.